BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 25085010)

  • 1. Discontinuation and non-adherence to endocrine therapy in breast cancer patients: is lack of communication the decisive factor?
    Wuensch P; Hahne A; Haidinger R; Meißler K; Tenter B; Stoll C; Senf B; Huebner J
    J Cancer Res Clin Oncol; 2015 Jan; 141(1):55-60. PubMed ID: 25085010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate cancer patients' report on communication about endocrine therapy and its association with adherence.
    Jung B; Stoll C; Feick G; Prott FJ; Zell J; Rudolph I; Huebner J
    J Cancer Res Clin Oncol; 2016 Feb; 142(2):465-70. PubMed ID: 26494234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Patterns of endocrine therapy in a national cohort of early stage HER2-positive breast cancer patients.
    Tervonen HE; Daniels B; Tang M; Preen DB; Pearson SA
    Pharmacoepidemiol Drug Saf; 2019 Jun; 28(6):812-820. PubMed ID: 30861596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Disentangling breast cancer patients' perceptions and experiences with regard to endocrine therapy: nature and relevance for non-adherence.
    Wouters H; van Geffen EC; Baas-Thijssen MC; Krol-Warmerdam EM; Stiggelbout AM; Belitser S; Bouvy ML; van Dijk L
    Breast; 2013 Oct; 22(5):661-6. PubMed ID: 23770134
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence status to Adjuvant Endocrine Therapy in Chinese Women with Early Breast Cancer and its influencing factors: A cross-sectional survey.
    Xu H; Jin F; Zhang XJ; Wang DQ; Yu SF; Wang AP
    Cancer Med; 2020 Jun; 9(11):3703-3713. PubMed ID: 32237070
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adherence to Adjuvant Endocrine Therapy in Women With Breast Cancer: A Prospective Observational Study in Japanese Women.
    Kuba S; Maeda S; Matsumoto M; Yamanouchi K; Yano H; Morita M; Sakimura C; Hatachi T; Tokai Y; Takatsuki M; Fujioka H; Hayashida N; Nagayasu T; Eguchi S
    Clin Breast Cancer; 2018 Apr; 18(2):150-156. PubMed ID: 29290564
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Medication taking behaviors among breast cancer patients on adjuvant endocrine therapy.
    Kimmick G; Edmond SN; Bosworth HB; Peppercorn J; Marcom PK; Blackwell K; Keefe FJ; Shelby RA
    Breast; 2015 Oct; 24(5):630-6. PubMed ID: 26189978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endocrine therapy adherence: a cross-sectional study of factors affecting adherence and discontinuation of therapy.
    Quinn EM; Fleming C; O'Sullivan MJ
    Ir J Med Sci; 2016 May; 185(2):383-92. PubMed ID: 25971465
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Good adherence to adjuvant endocrine therapy in early breast cancer - a population-based study based on the Swedish Prescribed Drug Register.
    Lundgren C; Lindman H; Rolander B; Ekholm M
    Acta Oncol; 2018 Jul; 57(7):935-940. PubMed ID: 29493327
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Persistence and discontinuation of adjuvant endocrine therapy in women with breast cancer.
    Kuba S; Ishida M; Nakamura Y; Taguchi K; Ohno S
    Breast Cancer; 2016 Jan; 23(1):128-133. PubMed ID: 24934610
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy for breast cancer: assessing an array of women's treatment experiences and perceptions, their perceived self-efficacy and nonadherence.
    Wouters H; Stiggelbout AM; Bouvy ML; Maatman GA; Van Geffen EC; Vree R; Nortier JW; Van Dijk L
    Clin Breast Cancer; 2014 Dec; 14(6):460-467.e2. PubMed ID: 24981234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Informing women with breast cancer about endocrine therapy: effects on knowledge and adherence.
    Heisig SR; Shedden-Mora MC; von Blanckenburg P; Schuricht F; Rief W; Albert US; Nestoriuc Y
    Psychooncology; 2015 Feb; 24(2):130-7. PubMed ID: 24953538
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modifiable risk factors for adherence to adjuvant endocrine therapy among breast cancer patients.
    Jacob Arriola KR; Mason TA; Bannon KA; Holmes C; Powell CL; Horne K; O'Regan R
    Patient Educ Couns; 2014 Apr; 95(1):98-103. PubMed ID: 24492157
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Barriers to and facilitative processes of endocrine therapy adherence among women with breast cancer.
    Bright EE; Petrie KJ; Partridge AH; Stanton AL
    Breast Cancer Res Treat; 2016 Jul; 158(2):243-51. PubMed ID: 27342455
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Factors Associated with Endocrine Therapy Non-Adherence in Breast Cancer Survivors.
    Spencer JC; Reeve BB; Troester MA; Wheeler SB
    Psychooncology; 2020 Apr; 29(4):647-654. PubMed ID: 32048400
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Real-world patterns of endocrine therapy for metastatic hormone-receptor-positive (HR+)/human epidermal growth factor receptor-2-negative (HER2-) breast cancer patients in the United States: 2002-2012.
    Swallow E; Zhang J; Thomason D; Tan RD; Kageleiry A; Signorovitch J
    Curr Med Res Opin; 2014 Aug; 30(8):1537-45. PubMed ID: 24669852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Adherence to adjuvant endocrine therapy in estrogen receptor-positive breast cancer patients with regular follow-up.
    Simon R; Latreille J; Matte C; Desjardins P; Bergeron E
    Can J Surg; 2014 Feb; 57(1):26-32. PubMed ID: 24461223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Geographic disparities in adherence to adjuvant endocrine therapy in Appalachian women with breast cancer.
    Tan X; Camacho F; Marshall VD; Donohoe J; Anderson RT; Balkrishnan R
    Res Social Adm Pharm; 2017; 13(4):796-810. PubMed ID: 27641308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient-reported Adherence to Adjuvant Aromatase Inhibitor Therapy Using the Morisky Medication Adherence Scale: An Evaluation of Predictors.
    Kesmodel SB; Goloubeva OG; Rosenblatt PY; Heiss B; Bellavance EC; Chumsri S; Bao T; Thompson J; Nightingale G; Tait NS; Nichols EM; Feigenberg SJ; Tkaczuk KH
    Am J Clin Oncol; 2018 May; 41(5):508-512. PubMed ID: 27322700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Barriers and facilitators to endocrine therapy adherence among underserved hormone-receptor-positive breast cancer survivors: a qualitative study.
    Wells KJ; Pan TM; Vázquez-Otero C; Ung D; Ustjanauskas AE; Muñoz D; Laronga C; Roetzheim RG; Goldenstein M; Carrizosa C; Nuhaily S; Johnson K; Norton M; Sims E; Quinn GP
    Support Care Cancer; 2016 Oct; 24(10):4123-30. PubMed ID: 27146492
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.